Want to see AU:IXC full AI Analyst Report?

Invex Therapeutics Ltd. (IXC) Income Statement

2 Followers

Invex Therapeutics Ltd. Income Statement

Last quarter (Q4 2026), Invex Therapeutics Ltd.'s total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Invex Therapeutics Ltd.'s net income was AU$-636.77K. See Invex Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
Total Revenue	AU$ 0.00	AU$ 229.08K	AU$ 1.21M	AU$ 459.08K	AU$ 182.25K
Gross Profit	AU$ 0.00	AU$ 229.08K	AU$ 1.21M	AU$ 459.08K	AU$ 182.25K
Operating Expenses	AU$ 1.54M	AU$ 938.39K	AU$ 3.35M	AU$ 8.98M	AU$ 4.22M
Depreciation and Amortization	AU$ 0.00	AU$ 709.30K	AU$ 2.13M	AU$ 8.55M	AU$ 0.00
EBITDA	AU$ -1.54M	AU$ 0.00	AU$ -720.37K	AU$ 337.94K	AU$ -4.14M
Operating Income	AU$ -1.54M	AU$ -709.30K	AU$ -2.13M	AU$ -8.55M	AU$ -4.03M
Other Income/Expenses	AU$ 145.25K	AU$ 232.44K	AU$ 491.82K	AU$ 797.08K	AU$ 79.88K
Pretax Income	AU$ -1.40M	AU$ -476.87K	AU$ -2.85M	AU$ -7.75M	AU$ -3.95M
Net Income	AU$ -1.35M	AU$ -476.87K	AU$ -1.64M	AU$ -7.75M	AU$ -3.95M
Per Share Metrics
Basic EPS	AU$ -0.02	AU$ -0.01	AU$ -0.02	AU$ -0.10	AU$ -0.05
Diluted EPS	AU$ -0.02	AU$ -0.01	AU$ -0.02	AU$ -0.10	AU$ -0.05
Weighted Average Shares Outstanding	75.15M	75.69M	75.31M	75.15M	75.15M
Weighted Average Shares Outstanding (Diluted)	75.15M	75.69M	75.31M	75.15M	75.15M

Currency in AUD

Invex Therapeutics Ltd. (IXC) Income Statement

Invex Therapeutics Ltd. Income Statement

Invex Therapeutics Ltd. Earnings and Revenue History